Decreased expression of GPC1 in human skin keratinocytes and epidermis during ageing.


Journal

Experimental gerontology
ISSN: 1873-6815
Titre abrégé: Exp Gerontol
Pays: England
ID NLM: 0047061

Informations de publication

Date de publication:
15 10 2019
Historique:
received: 04 10 2018
revised: 23 07 2019
accepted: 14 08 2019
pubmed: 21 8 2019
medline: 14 7 2020
entrez: 21 8 2019
Statut: ppublish

Résumé

Glypicans (GPCs) are heparan sulfate cell membrane proteoglycans containing glycosylphosphatidylinositol (GPI) anchor. They play important role in cell behavior by activating/presenting numerous growth factors and cytokines. The expression of GPCs was investigated in primary culture of skin keratinocytes sampled from healthy donors of different age. Primary keratinocytes from healthy female donors aged from 20 to 89 years old (n = 30) were either isolated from breast or abdominal skin samples (n = 27) or purchased (n = 3). GPCs expression was examined by qPCR, immunohistochemistry and western blot. Its role in proliferation induced by fibroblast growth factor 2 (FGF2) was also studied. Glypican 1 (GPC1) was the major expressed GPC in human keratinocytes. Its expression was up to two orders of magnitude higher than other GPCs and was significantly decreased with the age of the donors. It was localized at the cell surface and associated with intracellular granules. In skin sections, GPC1 was mainly localized in basal layer of epidermis. Shedding of GPCs decreased the proliferative effect of FGF2, confirming their role of modulator of growth factor effects on keratinocytes. These results established GPC1 as an important player in epidermis biology and skin ageing.

Sections du résumé

BACKGROUND
Glypicans (GPCs) are heparan sulfate cell membrane proteoglycans containing glycosylphosphatidylinositol (GPI) anchor. They play important role in cell behavior by activating/presenting numerous growth factors and cytokines.
OBJECTIVES
The expression of GPCs was investigated in primary culture of skin keratinocytes sampled from healthy donors of different age.
MATERIALS AND METHODS
Primary keratinocytes from healthy female donors aged from 20 to 89 years old (n = 30) were either isolated from breast or abdominal skin samples (n = 27) or purchased (n = 3). GPCs expression was examined by qPCR, immunohistochemistry and western blot. Its role in proliferation induced by fibroblast growth factor 2 (FGF2) was also studied.
RESULTS
Glypican 1 (GPC1) was the major expressed GPC in human keratinocytes. Its expression was up to two orders of magnitude higher than other GPCs and was significantly decreased with the age of the donors. It was localized at the cell surface and associated with intracellular granules. In skin sections, GPC1 was mainly localized in basal layer of epidermis. Shedding of GPCs decreased the proliferative effect of FGF2, confirming their role of modulator of growth factor effects on keratinocytes. These results established GPC1 as an important player in epidermis biology and skin ageing.

Identifiants

pubmed: 31430521
pii: S0531-5565(18)30634-X
doi: 10.1016/j.exger.2019.110693
pii:
doi:

Substances chimiques

GPC1 protein, human 0
Glypicans 0
RNA, Messenger 0
Fibroblast Growth Factor 2 103107-01-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110693

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

G Perrot (G)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France; BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

C Colin-Pierre (C)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France; BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

L Ramont (L)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France; CHU de Reims, Laboratoire Central de Biochimie, avenue du Général Koenig, 51092 Reims, France.

I Proult (I)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France.

C Garbar (C)

Institut Jean Godinot, 1 rue du Général Koenig, 51100 Reims, France.

V Bardey (V)

BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

C Jeanmaire (C)

BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

S Mine (S)

BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

L Danoux (L)

BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

N Berthélémy (N)

BASF Beauty Care Solutions France S.A.S, 3 rue de seichamps, 54425 Pulnoy, France.

F X Maquart (FX)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France.

Y Wegrowski (Y)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France.

S Brézillon (S)

CNRS UMR 7369, Université de Reims Champagne-Ardenne, Faculté de Médecine, 51 rue Cognacq Jay, 51095 Reims, France. Electronic address: stephane.brezillon@univ-reims.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH